Workflow
Apellis Pharmaceuticals (APLS) Reports Q3 Earnings: What Key Metrics Have to Say
APLSApellis(APLS) ZACKS·2024-11-05 15:36

Apellis Pharmaceuticals, Inc. (APLS) reported 196.83millioninrevenueforthequarterendedSeptember2024,representingayear−over−yearincreaseof78.3196.83 million in revenue for the quarter ended September 2024, representing a year-over-year increase of 78.3%. EPS of -0.46 for the same period compares to -1.17ayearago.Thereportedrevenuerepresentsasurpriseof−1.041.17 a year ago.The reported revenue represents a surprise of -1.04% over the Zacks Consensus Estimate of 198.89 million. With the consensus EPS estimate being -$0.32, the EPS surprise was -43.75%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Stre ...